ストックスクリーナーアプリを入手
15.02
0.47%
0.07
アフターアワーズ：
15.01
-0.010
-0.07%
Anika Therapeutics Inc (ANIK) 最新ニュース
Anika Therapeutics Inc (ANIK) Income Statement - TradingKey
Anika Therapeutics Inc (ANIK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anika Therapeutics Inc (ANIK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Anika Therapeutics Inc (ANIK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anika Therapeutics Inc (ANIK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anika Therapeutics Inc (ANIK) Cash Flow - TradingKey
Anika Therapeutics, Inc. Revenue Breakdown – BX:AKP - TradingView
Anika Therapeutics Inc (ANIK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anika Therapeutics (ANIK) 2026 CG Musculoskeletal Conference Summary - Quartr
Anika Therapeutics (ANIK) Proxy filing Summary - Quartr
Anika Therapeutics (ANIK) Q4 2025 earnings summary - Quartr
Anika Therapeutics (ANIK) AGM 2026 Summary - Quartr
BlackRock Portfolio Management (NASDAQ: ANIK) discloses 4.1% Anika Therapeutics ownership - Stock Titan
Discipline and Rules-Based Execution in ANIK Response - Stock Traders Daily
Anika Therapeutics Expands Revolving Credit Facility Agreement - The Globe and Mail
Anika Therapeutics to issue Q2FY26 results on July 29 - scanx.trade
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026 - GlobeNewswire
Anika Therapeutics Enters Fifth Amendment To Credit AgreementSEC Filing - TradingView
Anika Therapeutics Extends $50M Revolver to 2031 With Bank of America; Upsize Option to $100M - TradingView
Anika Therapeutics (NASDAQ: ANIK) updates $50M revolving credit line terms - Stock Titan
Anika Therapeutics, Inc. Amends and Extends $50 Million Senior Revolving Credit Facility with Bank Of America, N.A - marketscreener.com
Price to book forward of Anika Therapeutics Inc. – NASDAQ:ANIK - TradingView
Price to earnings forward of Anika Therapeutics Inc. – NASDAQ:ANIK - TradingView
Anika Therapeutics Edges Higher Amid Consolidation: ANIK Stock Tests Key ResistanceALMA Signal - dars.gov.et
Anika Therapeutics extends implant lifespan with engineered Hyaff for regenerative medicine - Traders Union
Anika Therapeutics, Inc.(NasdaqGS:ANIK) dropped from Russell 2000 Value-Defensive Index - marketscreener.com
Anika Therapeutics, Inc.(NasdaqGS: ANIK) dropped from Russell 2000 Defensive Index - marketscreener.com
Early MRI scans uncover hidden risks in rotator cuff repair, Integrity Implant System data show - Traders Union
Anika Therapeutics, Inc. Actuals & Estimates (NASDAQ:ANIK) - TradingView
ANIK Forecast — Price Target — Prediction for 2027 - TradingView
Anika Therapeutics unveils Hyalofast cartilage repair scaffold using Hyaff hyaluronic acid technology - Traders Union
Behavioral Patterns of ANIK and Institutional Flows - Stock Traders Daily
Anika Shareholders Approve Directors and Expanded Incentive Plans - TipRanks
Director at Anika Therapeutics (NASDAQ: ANIK) receives 10,402 RSU grant - Stock Titan
Director at Anika Therapeutics (ANIK) receives 10,402 RSU award, holding 58,273 shares - Stock Titan
Anika Therapeutics (ANIK) director awarded 10,402 RSUs in stock grant - Stock Titan
[Form 4] Anika Therapeutics, Inc. Insider Trading Activity - Stock Titan
Director at Anika Therapeutics (ANIK) receives 10,402 RSUs equity grant - Stock Titan
Anika Therapeutics increases equity plan shares under amended omnibus and ESPP - TradingView
Anika Therapeutics (NASDAQ: ANIK) shareholders back equity plans and director slate - Stock Titan
Anika Therapeutics Inc (ANIK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anika Therapeutics (ANIK) Q1 2026 Earnings: Massive EPS Surprise Driven by Operational EfficiencyGuidance vs Actual - dars.gov.et
Biologics may shift outcomes in tendon injuries, Anika Therapeutics explores - Traders Union
Anika Therapeutics Inc Annual Shareholders Meeting Transcript - GuruFocus
Anika Therapeutics Inc (ANIK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anika Therapeutics Inc (ANIK) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anika Therapeutics Inc (ANIK) Institutional Confidence - TradingKey
Anika Therapeutics introduces Cingal as only approved HA and corticosteroid combination for OA pain - Traders Union
(ANIK) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Anika Therapeutics (ANIK) Holds Steady Near Support Amid Low VolumeMonthly Profile - newsline.com
Anika Therapeutics Q1 2026 Earnings: Massive EPS Beat Fuels OptimismConsensus Forecast Report - newsline.com
Anika Therapeutics (ANIK) Edges Higher as Shares Test Key Resistance LevelsInside Day Breakout - newsline.com
Anika reports inducement grants - Medical Buyer
0.30%
2.01%
大文字化:
|
ボリューム (24 時間):